Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
|
US |
|
J
|
Jochu Technology Co Ltd
TWSE:3543
|
TW |
|
M
|
Mitsubishi Paper Mills Ltd
TSE:3864
|
JP |
|
Balfour Beatty PLC
LSE:BBY
|
UK |
|
A
|
Alpha IVF Group Bhd
KLSE:ALPHA
|
MY |
|
Afya Ltd
NASDAQ:AFYA
|
BR |
|
WNS (Holdings) Ltd
NYSE:WNS
|
IN |
|
P
|
Petrovietnam Chemical and Services Corp
VN:PVC
|
VN |
|
Kushikatsu Tanaka Holdings Co
TSE:3547
|
JP |
|
I
|
IX Biopharma Ltd
SGX:42C
|
SG |
|
K
|
Kelington Group Bhd
KLSE:KGB
|
MY |
|
Bechtle AG
XETRA:BC8
|
DE |
|
Unicharm Corp
TSE:8113
|
JP |
|
A
|
Argo Pantes Tbk PT
IDX:ARGO
|
ID |
|
I
|
Invesco Ltd
LSE:0UAN
|
US |
|
Coromandel International Ltd
NSE:COROMANDEL
|
IN |
|
S
|
SCI JSC
VN:S99
|
VN |
|
Lloyds Enterprises Ltd
NSE:LLOYDSENT
|
IN |
|
OHB SE
XETRA:OHB
|
DE |
Wall Street
Price Targets
ARWR Price Targets Summary
Arrowhead Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
ARWR
is 84.07 USD
with a low forecast of 35.35 USD and a high forecast of 115.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ARWR's stock price target?
Price Target
84.07
USD
According to Wall Street analysts, the average 1-year price target for
ARWR
is 84.07 USD
with a low forecast of 35.35 USD and a high forecast of 115.5 USD.
What is Arrowhead Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
22%
For the last 13 years the
compound annual growth rate for
Arrowhead Pharmaceuticals Inc's revenue is
100%.
The projected
CAGR
for the next 8 years is
22%.
What is Arrowhead Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
46%
The
compound annual growth rate
of Arrowhead Pharmaceuticals Inc's operating income for the next 8 years is
46%.
